About
Biovault Technical
Our Mission
Our Team
Facilities
Biovault Family
Quality
Accreditations
Advisory Board
Partnerships
Testimonials
Services
Cellular Therapy Processing
Biobanking
Allografts
Support services
Consultancy
Contingency Planning & Business Continuity
Insights
All
Cellular Therapies
Company News
Educational Resources
Ethical Approach
Industry Events
Innovation
Quality & Safety
Regulatory Compliance
Sustainability
Get in touch

Biovault Technical

About
Biovault Technical
Our Mission
Our Team
Facilities
Biovault Family
Quality
Accreditations
Advisory Board
Partnerships
Testimonials
Services
Cellular Therapy Processing
Biobanking
Allografts
Support services
Consultancy
Contingency Planning & Business Continuity
Insights
All
Cellular Therapies
Company News
Educational Resources
Ethical Approach
Industry Events
Innovation
Quality & Safety
Regulatory Compliance
Sustainability
Get in touch
6 May 2026
Quality & Safety, Regulatory Partnerships, Cellular Therapies, Innovation, Ethical Practices
Sarah Conway
Donor lymphocyte infusions: from reactive ...

Donor lymphocyte infusions (DLI) and clinical readiness. Discover Biovault’s pre-prepared DLI processing and storage approach for faster access and reduced risk.

Donor lymphocyte infusions: from reactive intervention to clinical readiness
30 March 2026
Industry Events, Company News, Cellular Therapies
Sarah Conway
EBMT 2026: 5 Insights Shaping the Future of ...

5 key takeaways from EBMT 2026, from expanded cord blood and JACIE quality to regulation, infrastructure and the future of cell therapy.

EBMT 2026: 5 Insights Shaping the Future of Cell Therapy
10 February 2026
Cellular Therapies, Innovation
Sarah Conway
The Evolution of Cell Therapy Part 3: Immune ...

Explore how PBSCs enabled CAR-T and immune effector cell therapies, and how Biovault supports safe processing, storage and delivery of advanced cellular medicines.

The Evolution of Cell Therapy Part 3: Immune Effector Cell Therapies
1 December 2025
Cellular Therapies
Sarah Conway
The Evolution of Cell Therapy Part 2: ...

How peripheral blood stem cells became the preferred source for transplantation, and how Biovault supports PBSC collection pathways through compliant processing and storage.

The Evolution of Cell Therapy Part 2: Peripheral Blood Stem Cells
29 September 2025
Innovation
Sarah Conway
Engineering Cellular Therapy Tools: How ...

How Biovault Technical engineered new cryoshipper racks and CRF freezer racks to enhance safety, usability and compliance for cellular therapies.

Engineering Cellular Therapy Tools: How Biovault Built Better Cryo Racks
Sarah Conway
26 February 2025
Cellular Therapies, Quality & Safety

Biovault: Advancing Cellular Therapy Processing for Oncology and Haematology

Sarah Conway
26 February 2025
Cellular Therapies, Quality & Safety
Biovault: Advancing Cellular Therapy Processing for Oncology and Haematology

Discover how Biovault supports oncologists and haematologists with bespoke stem cell processing, storage and logistics services for regenerative cellular therapies.

Sarah Conway
5 December 2024
Regulatory Partnerships, Cellular Therapies, Innovation

Biovault Technical Achieves Milestone with MHRA Wholesale Dealers Authorisation

Sarah Conway
5 December 2024
Regulatory Partnerships, Cellular Therapies, Innovation
Biovault Technical Achieves Milestone with MHRA Wholesale Dealers Authorisation

The MHRA has granted Biovault Technical a WDA license, enabling the distribution of medicinal products and advancing cell therapy access in Plymouth and the UK.

Sarah Conway
25 October 2024
Company News, Innovation

Redefining our bioresourceful business

Sarah Conway
25 October 2024
Company News, Innovation
Redefining our bioresourceful business

Biovault is more than a biobank. We are a bioresource offering stem cell processing, allografts, support services and consultancy, as well as biobanking you can trust.

Sarah Conway
9 September 2024
Cellular Therapies, Innovation

Lab-grown HSCs expand the future of cell therapy, and biobanking

Sarah Conway
9 September 2024
Cellular Therapies, Innovation
Lab-grown HSCs expand the future of cell therapy, and biobanking

Lab-grown stem cells may revolutionise cancer treatment by reducing the need for donors. What does this mean for bioresources like Biovault? 

Sarah Conway
23 July 2024
Ethical Practices, Innovation, Sustainability, Educational Resources

Biovault Reduces, Reuses, Recycles and Inspires in Bid to Combat Plastics & Waste

Sarah Conway
23 July 2024
Ethical Practices, Innovation, Sustainability, Educational Resources
Biovault Reduces, Reuses, Recycles and Inspires in Bid to Combat Plastics & Waste

The UK healthcare sector produces hundreds of thousands of tonnes of waste every year. At Biovault, we’re working to reduce waste in every area and have been inspired by the difference it makes.

Sarah Conway
29 May 2024
Industry Events, Company News, Cellular Therapies

EBMT Round up: 5 Key Takeaways from Glasgow 2024

Sarah Conway
29 May 2024
Industry Events, Company News, Cellular Therapies
EBMT Round up: 5 Key Takeaways from Glasgow 2024

EBMT 2024 was an inspiring event combining a patient-first ethos with insights from cellular therapy pioneers. We share our Top 5 Takeaways.

Newer Posts
Older Posts
Back to Top
Biovault Technical Ltd, Plymouth International Medical & Technology Park, 24 Brest Road, Derriford, Plymouth, PL6 5XP, United Kingdom+44 1752 753720info@biovaulttechnical.co.uk

address

Biovault Technical
24 Brest Road
Plymouth, PL6 5XP
View on map

TELEPHONE

+44 (0)1752 753720

enquiries

info@biovaulttechnical.co.uk

careers

COOKIE POLICY

Privacy Policy

CONTACT